Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
FORTE Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
A Multicenter Study of 5-Aminolevulinic Acid 5-ALA to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Study Type: Prevention
Phase: III
NCTID: NCT02851407
Principal Investigator:
Rakesh Goyal
A Phase IIb Clinical Trial of the Multitargeted Recombinant Adenovirus 5 CEA/MUC1/Brachyury Vaccines Tri-Ad5 and IL-15 Superagonist N-803 in Lynch syndrome
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk
A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
Phase IIB pre-surgical trial of oral tamoxifen TAM versus transdermal 4-hydroxytamoxifen 4-OHT in women with DCIS of the breast
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women with Obesity and Other Risk Factors for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT06485089
Principal Investigator:
Carol Fabian
Phase 2 Study of Low Dose Tamoxifen +/- High Dose Omega-3 Fatty Acids in Overweight Postmenopausal Women at Increased Risk for Breast Cancer
Study Type: Prevention
Phase: II
NCTID: NCT06195306
Principal Investigator:
Lauren Nye